---
title: "Shanghai Pharma (601607.SH) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/601607.SH/norm.md"
symbol: "601607.SH"
name: "Shanghai Pharma"
parent: "https://longbridge.com/en/quote/601607.SH.md"
datetime: "2026-05-21T15:05:53.930Z"
locales:
  - [en](https://longbridge.com/en/quote/601607.SH/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/601607.SH/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/601607.SH/norm.md)
---

# Shanghai Pharma (601607.SH) — Financial Reports

## Income Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.3823 | 0.1514 | 0.1864 | 0.8393 | 0.3595 |
| ROE | 7.40% | 3.05% | 3.65% | 16.88% | 7.37% |
| Revenue | 75.26B | 68.51B | 73.48B | 70.83B | 70.76B |
| Net income | 1.42B | 577.49M | 688.20M | 3.13B | 1.33B |
| Operating income | 2.63B | 2.04B | 1.88B | 2.27B | 2.28B |
| Gross margin | 10.75% | 11.61% | 10.14% | 10.89% | 10.25% |
| Net margin | 1.88% | 0.84% | 0.94% | 4.41% | 1.88% |
| Profit quality | -260.20% | 53.60% | 137.94% | 71.01% | -103.39% |

## Balance Sheet (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 235.37B | 233.15B | 236.75B | 238.07B | 225.87B |
| Leverage | 2.57 | 2.60 | 2.64 | 2.68 | 2.65 |
| BVPS | 20.85 | 20.46 | 20.44 | 20.25 | 19.69 |
| Turnover | 1.25 | 1.25 | 1.22 | 1.21 | 1.24 |
| Cash & STI | 41.12B | 43.08B | 44.55B | 47.55B | 45.03B |
| Inv & Rec | 41.68B | 45.36B | 41.78B | 40.90B | 37.82B |
| LT assets | 19.24B | 19.29B | 18.99B | 19.24B | 19.15B |
| Net debt | 17.72B | 14.14B | 14.36B | 13.63B | 14.42B |

## Cash Flow Statement (CNY)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.01B | 3.80B | 1.36B | 3.19B | -2.20B |
| Investing CF | -286.77M | -3.19B | 449.96M | -267.33M | -972.94M |
| Financing CF | 152.34M | -5.10B | -4.31B | -110.83M | 3.86B |
| Free CF | -4.35B | 3.58B | -2.90B | 3.47B | -5.79B |
| OCF coverage | -4.27% | 19.58% | 7.45% | 17.06% | -11.05% |
| Repaid & issued | 23.21B | 13.30B | 14.29B | 18.72B | 23.07B |
| CapEx | -687.11M | -713.68M | -487.63M | -394.61M | -729.97M |

## Distribution Plan

**Dividend Yield**: 2.48

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.12CNY | 2025-12-31 | 2026-01-05 | 2026-01-05 |
| Cash Dividend: 
0.29CNY | 2025-07-17 | 2025-07-18 | 2025-07-18 |
| Cash Dividend: 
0.08CNY | 2024-09-23 | 2024-09-24 | 2024-09-24 |